|
|
Effect of Enalapril combined with Trimetazidine in the treatment of elderly patients with chronic heart failure |
YANG Shao-jun |
Department of Cadre Health Care,Sun Yat-Sen Hospital Affiliated to Xiamen University,Fujian Province,Xiamen 361004,China |
|
|
Abstract Objective To explore the effect of Enalapril combined with Trimetazidine in the treatment of elderly patients with chronic heart failure(CHF)and the effect on N-terminal pro-B-type natriuretic peptide(NT-proBNP)and cardiac function.Methods A total of 96 elderly patients with CHF treated in our hospital from November 2016 to October 2017 were selected as objects.They were randomly divided into research group and control group according to the random number table method,with 48 cases in each group.In the control group,Trimetazidine was used on the basis of routine treatment,and in the research group,Enalapril was adopted on the basis of the control group.The clinical efficacy,the NT-proBNP and cardiac function indexes before and after treatment between the two groups were compared.Results The total therapeutic effective rate of the research group was significantly higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the level of Left Ventricular Ejection Fractions(LVEF)in the research group was significantly higher than that of the control group,the levels of Left Ventricular End-Diastolic dimension (LVEDD),Left Ventricular End-Systolic Diameter(LVESD)and NT-proBNP were significantly lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Enalapril combined with Trimetazidine is effective in the treatment of elderly patients with CHF,which can significantly improve the NT-proBNP level and cardiac function of patients,and is worthy of clinical application.
|
|
About author:: 杨少君(1981-),女,福建厦门人,硕士,副主任医师,研究方向:心血管内科 |
|
|
|
[1] |
李志勇,冯云飞,杨东辉.老龄慢性心力衰竭患者的临床特点和治疗原则[J/CD].中华临床医师杂志(电子版),2015,9(12):2271-2275.
|
[2] |
付丽,程洁.马来酸依那普利叶酸片对老年慢性心力衰竭患者血清和肽素、N-末端B型利钠肽前体及同型半胱氨酸水平的影响研究[J].实用心脑肺血管病杂志,2015,23(11):59-61.
|
[3] |
周素芹,童嘉毅,朱从飞,等.奥美沙坦酯对慢性心力衰竭患者心功能、血浆N端脑钠肽前体和血清白细胞介素23水平的影响[J].中国药房,2017,28(29):4126-4129.
|
[4] |
赵世明.依那普利联合卡维地洛对慢性心力衰竭患者心功能、神经内分泌功能及血管内皮功能的影响研究[J].实用心脑肺血管病杂志,2016,24(3):19-22.
|
[5] |
董晓瑞,臧兵兵.马来酸依那普利叶酸片治疗老年慢性心力衰竭临床疗效观察[J].重庆医学,2017,46(5):685-687.
|
[6] |
高桂丽.曲美他嗪对冠状动脉粥样硬化性心脏病合并慢性心力衰竭患者心功能指标及血清NT-proBNP水平的影响[J].国际医药卫生导报,2017,23(5):701-704.
|
[7] |
刘伟.卡维地洛联合依那普利对老年慢性心力衰竭的疗效评价[J].医学综述,2015,21(6):1146-1148.
|
[8] |
刘健,肖霞,郑月元,等.依那普利联合环磷腺苷葡胺对心力衰竭患者心功能、血浆脑利钠肽浓度的影响[J].河北医药,2016,38(2):255-257.
|
[9] |
刘永建,齐洪娜,李佳,等.贝那普利联合曲美他嗪对老年冠心病并发慢性心力衰竭患者的炎性细胞因子及心功能的影响[J].广西医学,2016,38(5):644-647.
|
[10] |
余湘宁,黄宇辉,王晓冬.阿托伐他汀联合曲美他嗪对慢性心力衰竭患者血浆氮末端-脑钠肽前体水平及心功能的影响[J].广州医科大学学报,2015,43(1):13-16.
|
[11] |
岳胜,李莉.依那普利对慢性心衰患者神经内分泌的影响[J].北方药学,2015,14(5):101-102.
|
[12] |
董晓瑞.马来酸依那普利叶酸片治疗老年慢性心力衰竭临床疗效观察[J].重庆医学,2017,46(5):685-687.
|
[13] |
李小成.依那普利联合曲美他嗪治疗充血性心力衰竭的临床疗效及对脑钠肽水平的影响[J].中国医师进修杂志,2013,36(31):66-68.
|
[14] |
倪红芬,黄小燕,崔力军,等.NT-proBNP及Hcy联合检测在老年抑郁症合并慢性心衰患者诊治中的应用价值[J].中国现代医生,2014,52(27):54-56.
|
[15] |
张俊平,尤忠孝,李峰.NT-ProBNP在心力衰竭诊断中临床应用[J].疾病监测与控制,2015,9(2):113-114.
|
|
|
|